Sinopharm Group Co. Ltd. (HKG:1099)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Distribution	435.39B	444.36B	441.05B	406.60B	389.95B
Pharmaceutical Distribution Growth	-2.02%	0.75%	8.47%	4.27%	11.96%
Medical Devices	115.54B	117.92B	130.21B	120.85B	108.13B
Medical Devices Growth	-2.02%	-9.44%	7.75%	11.77%	20.95%
Retail Pharmacy	38.38B	35.98B	35.69B	32.98B	29.06B
Retail Pharmacy Growth	6.67%	0.82%	8.22%	13.49%	20.26%
Eliminations	-23.00B	-22.86B	-20.77B	-18.50B	-15.91B
Other Business	8.85B	9.11B	10.39B	10.21B	9.82B
Other Business Growth	-2.78%	-12.32%	1.73%	3.95%	28.35%
Total	575.17B	584.51B	596.57B	552.15B	521.05B
Total Growth	-1.60%	-2.02%	8.05%	5.97%	14.16%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
People's Republic of China (PRC)	575.17B	584.51B	596.57B	552.15B	521.05B
People's Republic of China (PRC) Growth	-1.60%	-2.02%	8.05%	5.97%	14.16%
Total	575.17B	584.51B	596.57B	552.15B	521.05B
Total Growth	-1.60%	-2.02%	8.05%	5.97%	14.16%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error